(Q53351501)

13 May 2018

review article

1 reference

title

WHO cytokine standardization: facilitating the development of cytokines in research, diagnosis and as therapeutic agents. (English)

1 reference

13 May 2018

author name string

Mire-Sluis AR

series ordinal

1

1 reference

13 May 2018

Das RG

series ordinal

2

1 reference

13 May 2018

Padilla A

series ordinal

3

1 reference

13 May 2018

publication date

1 July 1998

1 reference

13 May 2018

Journal of Immunological Methods

published in

1 reference

13 May 2018

volume

216

1 reference

13 May 2018

issue

1-2

1 reference

13 May 2018

page(s)

103-116

1 reference

13 May 2018

Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

International collaborative study of the candidate international standards for human tumour necrosis factors alpha (hTNF-alpha) and beta (hTNF-beta) and for murine tumour necrosis factor alpha (mTNF-alpha).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Evaluation of assay designs for assays using microtitre plates: results of a study of in vitro bioassays and immunoassays for tumour necrosis factor (TNF).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standards for interleukin-1 alpha and interleukin-1 beta. Evaluation in an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for interleukin-6. Evaluation in an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Iterative weighted regression analysis of logit responses: a computer program for analysis of bioassays and immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for human interleukin-2. Calibration by international collaborative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Interlaboratory comparison of radioimmunoassay results. Variation produced by different methods of calculation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Predicting the Stability of Biological Standards and Products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Design and analysis of accelerated degradation tests for the stability of biological standards III. Principles of design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Design and analysis of accelerated degradation tests for the stability of biological standards II. A flexible computer program for data analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Cytokines--protein structure and biological activity: a complex relationship with implications for biological assays and standardization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for macrophage colony stimulating factor (M-CSF). Evaluation in an international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for granulocyte colony stimulating factor (G-CSF). Evaluation in an international collaborative study. Participants of the Collaborative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Immunoassays for detecting cytokines: What are they really measuring?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Implications for the assay and biological properties of interleukin-3. Results of a WHO international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Implications for the assay and biological activity of interleukin-4. Results of a WHO international collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The biological properties, assay, and standardization of interferon-alpha: a need for a WHO collaborative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Biological assays: their role in the development and quality control of recombinant biological medicinal products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Implications for the assay and biological activity of interleukin-8: results of a WHO international collaborative study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for basic fibroblast growth factor (FGF-2); comparison of candidate preparations by in vitro bioassays and immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

The international standard for epidermal growth factor (EGF): comparison of candidate preparations by in vitro bioassays and immunoassays. National Institute for Biological Standards and Control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Additives to biological substances. II. Relative stabilities of some carbohydrate additives at and around neutral pH values in phosphate buffers and water

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

Additives to biological substances. I. Effect of added carbohydrates on bovine serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2898%2900073-8

10.1016/S0022-1759(98)00073-8

7 January 2021

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018